Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
Blood|September 24, 2004
Immune responses and tolerance to the RhD blood group protein in HLA-transgenic miceAndrew M Hall, Lindsay S Cairns, Daniel M Altmann, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 4, 2009
HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic miceNathali Kaushansky, Daniel M Altmann, Stephanie Ascough, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenesMeera Unnikrishnan, Daniel M Altmann, Thomas Proft, et al.Immunology|May 9, 2008
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cellsJeremy D Isaacs, Oliver A Garden, Gurman Kaur, et al.Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.Immunology|March 6, 2012
The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculationDeborah L W Chong, Rebecca J Ingram, Daniel E Lowther, et al.Arthritis and Rheumatism|February 1, 2006
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse modelAlexei von Delwig, Daniel M Altmann, John D Isaacs, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2009
HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 alleleVictor Zota, Anna Nemirovsky, Rona Baron, et al.Annals of the Rheumatic Diseases|November 23, 2006
T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic miceAlexei von Delwig, Daniel M Altmann, Fraser G Charlton, et al.Immunology|February 14, 2022
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19Stuart Astbury, Catherine J Reynolds, David K Butler, et al.Pageof 13